TP53 and liver cancer: For example, methyl-β-cyclodextrin, which removes plasma membrane cholesterol, has been reported to sensitize breast and liver cancer cells to doxorubicin by enhancing p53 protein level and its nuclear localization, leading to increased cell membrane expression of FasR and activation of the extrinsic apoptotic pathway [88].